Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,212
Closed -$1.18M 71
2024
Q1
$1.18M Sell
1,212
-18
-1% -$16K 0.98% 22
2023
Q4
$931K Sell
1,230
-21
-2% -$13.9K 0.8% 28
2023
Q3
$736K Buy
1,251
+22
+2% +$14.6K 0.69% 36
2023
Q2
$891K Sell
1,229
-3
-0.2% -$2.04K 0.82% 25
2023
Q1
$839K Buy
1,232
+31
+3% +$19.9K 0.78% 26
2022
Q4
$656K Buy
+1,201
New +$629K 0.61% 32

Other funds holding ASML

Cravens & Co Advisors's ASML Position: Q2 2024 in Review

Cravens & Co Advisors sold out of ASML (ASML) in Q2 2024, closing a stake of 1,212 shares — an estimated $1.18M sold.

Cravens & Co Advisors first reported a position in ASML in Q4 2022 and held it in 6 quarters. The position peaked at $1.18M in Q1 2024. 1,597 funds tracked by Wall St. Rank hold ASML as of Q2 2024.

  • Cravens & Co Advisors reported no remaining ASML position as of Q2 2024 after selling out during the quarter.
  • Cravens & Co Advisors sold 1,212 ASML shares in Q2 2024, an estimated $1.18M.
  • Cravens & Co Advisors first reported a position in ASML in Q4 2022 and held it in 6 quarters.
  • Cravens & Co Advisors's ASML position peaked at $1.18M in Q1 2024.
  • 1,597 funds tracked by Wall St. Rank held ASML as of Q2 2024.

Based on Cravens & Co Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.